| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | WH-4-023 | GDSC1000 | pan-cancer | AAC | -0.061 | 0.2 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | AZD-2281 | FIMM | pan-cancer | AAC | 0.21 | 0.2 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | -0.04 | 0.2 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.036 | 0.2 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | -0.041 | 0.2 |
| mRNA | IPA-3 | GDSC1000 | pan-cancer | AAC | 0.041 | 0.2 |
| mRNA | CGP-082996 | GDSC1000 | pan-cancer | AAC | -0.063 | 0.2 |
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | 0.04 | 0.2 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | -0.043 | 0.2 |